Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 08:18:36 2026-08-21 am EDT			5-day change	1st Jan Change
59.68 ^EUR	-0.38%		+3.02%	-5.98%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.58B		BBB
ELI LILLY AND COMPANY	1,109B		A
JOHNSON & JOHNSON	644B	-	BBB	-	-
ABBVIE INC.	463B		AA		-
ROCHE HOLDING AG	371B		AA
NOVARTIS AG	301B		AAA
ASTRAZENECA PLC	256B		A
AMGEN INC.	234B		A
NOVO NORDISK A/S	205B		A
GILEAD SCIENCES, INC.	178B		AA
PFIZER INC.	158B		A
VERTEX PHARMACEUTICALS INCORPORATED	137B		AA
BRISTOL-MYERS SQUIBB COMPANY	134B		A
SANOFI	109B		AA
GSK PLC	105B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	73.59B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	58.59B		AA
BAYER AG	55.78B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	48.45B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	42.89B		-
Average	234.34B		AA
Weighted average by Cap.			AA